The Pre-Jowl Strategy: Lower Cheek Fillers Paired with Jawline Bio-Remodelling

One of the most common concerns patients bring to aesthetic consultations is the gradual softening of the lower face — a subtle but persistent loss of definition along the jaw and the early formation of jowls. Many people notice this shift in their thirties and forties and find themselves searching online for approaches that address these changes without surgery.

The term "pre-jowl strategy" refers to a considered, proactive approach to lower facial ageing — one that focuses on restoring structural support through lower cheek fillers and improving skin quality and tissue resilience along the jawline through bio-remodelling treatments. Used in combination, these two modalities may complement one another in ways that a single treatment approach cannot.

This article explains what lower cheek fillers and jawline bio-remodelling involve, the facial ageing science underpinning this combined approach, who may benefit from a professional assessment, realistic expectations, and important considerations around risks and limitations. As with all aesthetic treatments, suitability depends entirely on individual assessment by a qualified practitioner.

The pre-jowl strategy combines lower cheek dermal fillers — used to restore structural volume and lift along the lateral lower face — with jawline bio-remodelling, which uses injectable hyaluronic acid to improve skin hydration, elasticity, and tissue quality. Together, they aim to address early jowling and the gradual loss of lower facial definition. Suitability must always be assessed individually by a qualified practitioner.

To appreciate why lower cheek fillers and jawline bio-remodelling are sometimes used together, it helps to understand the mechanisms that cause the lower face to change with age.

Facial ageing is multifactorial. It occurs simultaneously at the level of the skin, soft tissue, fat compartments, muscle, and underlying bone. From the mid-thirties onwards, several key changes typically accelerate:

• Collagen and elastin depletion: The dermis loses structural proteins responsible for skin firmness and resilience. Collagen production slows and existing fibres fragment, contributing to skin laxity.
• Volume redistribution: Facial fat compartments atrophy, descend, or shift. The malar fat pad (cheek fat) is particularly prone to descent, which reduces lateral cheek support and allows soft tissue to accumulate along the jawline — a primary driver of jowl formation.
• Bone remodelling: The mandible and mid-face skeleton remodel over time, reducing bony projection and the structural scaffolding that supports overlying tissues.
• Ligamentous laxity: Retaining ligaments that anchor soft tissue to bone become less taut, allowing tissues to migrate inferiorly.

The result is a softening of the jawline, deepening of the nasolabial fold and marionette lines, and the characteristic jowl — a protrusion of descended tissue just below and around the jaw border.

Understanding these changes is essential context for appreciating how a combination approach, targeting both structure and skin quality, may offer a more considered response than a single intervention.

Lower cheek fillers refer to the placement of hyaluronic acid-based dermal fillers in the lower lateral cheek and pre-jowl region — the area along and above the jawline where volume loss and tissue descent often become visible as early jowling.

Unlike treatments that focus on upper cheek projection, lower cheek fillers aim to address the structural deficit that contributes to jaw border irregularity. By restoring volume in a targeted location, the practitioner aims to re-establish the lateral support that helps define the transition between the cheek and jaw.

Hyaluronic acid fillers used in this area are typically of a firmer consistency, selected for their capacity to provide lift and structural support rather than superficial hydration. The precise placement depth and product selection are important technical considerations that vary between individuals.

This is a well-established application of dermal filler techniques within aesthetic medicine, though it requires careful assessment of facial anatomy, skin quality, and the degree of tissue descent before any treatment plan is formed. It is not appropriate for all patients, and individual consultation is essential.

You can explore how marionette line filler treatment is used as part of a broader lower-face assessment.

Bio-remodelling is a category of injectable treatment that uses a high concentration of hyaluronic acid — often in a distinctively formulated, uncrosslinked or hybrid-crosslinked form — to stimulate the skin's own regenerative activity rather than simply adding volume.

When injected along the jawline and lower face, bio-remodelling products are designed to disperse through the tissue, promoting collagen and elastin synthesis, improving skin hydration at a deep level, and enhancing the overall quality and resilience of the skin envelope.

Jawline bio-remodelling is often described as a skin quality treatment rather than a volumising treatment. Its primary aim is to improve the elasticity, firmness, and hydration of skin in the lower face — which may help the overlying tissue respond better to structural support provided by fillers and contribute to a more refined jawline appearance over time.

The treatment typically involves a small number of strategic injection points along the jaw. Results are generally gradual, with improvements in skin quality developing over several weeks as the bio-remodelling process stimulates the dermal matrix.

As with all injectable treatments, risks exist and not every patient will respond in the same way. A thorough consultation is required before proceeding.

The combination of lower cheek fillers and jawline bio-remodelling is grounded in a logical clinical rationale: addressing lower facial ageing at two distinct levels simultaneously — structural support and skin quality.

Dermal fillers address the volumetric and structural component of early jowling by restoring lateral cheek support and blending the contour transition from cheek to jaw. However, fillers alone cannot improve the quality, elasticity, or hydration of the skin itself.

Bio-remodelling, conversely, can meaningfully improve skin quality and stimulate collagen production, but it does not provide structural volume or mechanical lift where significant tissue descent has occurred.

When used together — and sequenced appropriately by a qualified practitioner — the two treatments may offer complementary benefits:

• Fillers provide structural scaffolding in the lower cheek and pre-jowl area.
• Bio-remodelling improves the skin envelope, supporting tissue resilience and potentially prolonging the overall aesthetic effect.

For patients also dealing with jaw tension or lower-face widening, this guide on masseter comfort and jawline definition can add useful context.

It is important to note that outcomes vary between individuals, and not all patients will benefit equally from a combined approach. Some may require only one modality. Others may need additional assessment before any treatment is considered suitable. The decision should always be made following a thorough in-person consultation.

A professional assessment may be appropriate for patients who notice any of the following changes in the lower face:

• Early jowl formation: A mild fullness or descent of tissue just below the jaw border, particularly visible in profile.
• Softening of the jaw angle: Reduced definition between the cheek and jaw, contributing to a less defined lower face outline.
• Skin laxity along the jawline: Skin that feels or appears less firm than previously, without significant excess.
• Volume loss in the lateral lower cheek: A flattening or hollowing below the cheekbone that contributes to the jowl appearance by reducing support.
• Skin quality concerns: Reduced skin hydration, elasticity, or texture in the lower face and jawline region.

These changes are normal aspects of facial ageing and do not require treatment. However, for patients who feel that these changes are affecting their confidence or prompting questions about their options, a consultation with a qualified aesthetic practitioner can help them understand what may be appropriate for their individual anatomy and concerns.

It is important to approach these consultations with realistic expectations. A practitioner's role is to assess suitability, explain options, discuss risks, and support informed decision-making — not to recommend treatment unnecessarily.

Potential Benefits

When assessed as suitable and performed by a qualified practitioner, a combined lower cheek filler and jawline bio-remodelling approach may:

• Contribute to a softer, more blended jaw contour in patients with early jowling.
• Support skin quality improvements along the lower face over time.
• Provide a non-surgical option for patients who are not ready for or interested in surgical intervention.
• Offer a relatively low-downtime treatment experience compared to surgical alternatives.

Realistic Limitations

It is equally important to understand what this combination approach cannot achieve:

• It is not a substitute for surgical procedures such as a lower face or neck lift, where significant tissue laxity or excess is present.
• Results are not permanent. Hyaluronic acid fillers are gradually metabolised by the body. Bio-remodelling effects also diminish over time without maintenance.
• Response varies. Individual factors including skin quality, degree of tissue descent, lifestyle, and overall health influence outcomes significantly.
• It does not address all causes of lower facial ageing. Factors such as bone remodelling, muscle activity, and significant skin laxity may require additional or different approaches.

Managing Expectations

Patients should approach any aesthetic treatment with an understanding that results are likely to be gradual, subtle, and variable. An experienced practitioner will discuss realistic outcomes during consultation and will not proceed if they do not consider treatment appropriate for the individual.

As with all injectable aesthetic treatments, lower cheek fillers and jawline bio-remodelling carry risks. These include, but are not limited to:

• Bruising and swelling: Common and typically temporary, resolving within days to two weeks.
• Tenderness or discomfort: At and around injection sites, usually short-lived.
• Asymmetry: Uneven results, which may require review or correction.
• Nodules or irregularities: Particularly with dermal fillers; often manageable but requiring practitioner assessment.
• Infection: Rare, but a recognised risk with any injectable procedure.
• Vascular occlusion: An uncommon but serious complication specific to dermal fillers, where filler inadvertently occludes a blood vessel. This underlines the importance of treatment by appropriately trained medical professionals with access to hyaluronidase (the enzyme used to dissolve hyaluronic acid filler in the event of a complication).
• Allergic or hypersensitivity reactions: Uncommon but possible.

The importance of selecting a qualified, appropriately trained practitioner — ideally a medical professional working in a regulated clinical environment — cannot be overstated. Patients are encouraged to ask about practitioner qualifications, clinical governance, and complication management protocols before proceeding with any treatment.

The longevity of results from both treatments varies between individuals and is influenced by several factors, including:

• Metabolic rate: Individuals metabolise hyaluronic acid at different rates.
• Lifestyle factors: Sun exposure, smoking, alcohol consumption, and hydration all influence skin quality and treatment longevity.
• Product type: Different filler formulations and bio-remodelling products have varying longevity profiles.
• Degree of facial movement: The lower face is an area of significant dynamic activity, which can influence how quickly fillers are metabolised.

As a general guide, lower cheek fillers may last between 9 and 18 months, though this varies. Bio-remodelling treatments often involve an initial course of two sessions, with maintenance typically recommended every 6 to 12 months. A practitioner will advise on an appropriate schedule based on individual assessment and response to treatment.

Following injectable treatments in the lower face, patients are generally advised to:

• Avoid strenuous exercise for 24–48 hours post-treatment to minimise swelling and bruising.
• Avoid alcohol and blood-thinning medications (where medically appropriate) in the days immediately following treatment.
• Avoid excessive heat — including saunas, steam rooms, and intense sun exposure — for at least 48 hours.
• Avoid touching or massaging the treated area unless specifically advised to do so by the treating practitioner.
• Apply SPF 30 or above daily as part of an ongoing skincare routine. Sun protection is important year-round for skin health and longevity of aesthetic treatment results.
• Stay well hydrated and maintain a balanced diet to support overall skin health.
• Follow practitioner-specific aftercare instructions carefully, as guidance may vary depending on the products used and individual circumstances.

If any unexpected symptoms occur following treatment — including significant swelling, severe pain, skin discolouration, or vision changes — patients should contact their practitioner immediately.

Maintaining long-term skin health through a consistent, evidence-supported skincare routine — including cleansing, moisturising, sun protection, and where appropriate, active ingredients such as retinoids or peptides — supports the skin between treatments. Patients may benefit from discussing their skincare regimen with their practitioner at consultation.

If you are considering a broader approach to facial skin health, exploring Profhilo treatment may provide useful context during your research.

Aesthetic medicine, at its best, begins with a thorough and unhurried consultation. Before any treatment is considered, a qualified practitioner should:

• Conduct a detailed facial assessment, including skin quality, tissue laxity, facial anatomy, and the degree of any volume loss.
• Review the patient's medical history, current medications, and any relevant contraindications.
• Discuss realistic expectations, potential risks, and alternative options.
• Explain the proposed treatment plan clearly and in language the patient understands.
• Obtain properly informed consent before proceeding.

Patients who are researching treatments online should feel encouraged to bring their questions to a consultation — there are no obligations attached to a discussion, and a good practitioner will support informed, autonomous decision-making without pressure.

To discuss your concerns about lower facial ageing with a qualified practitioner in London, you may wish to book a consultation at Pantaleo to explore whether any treatment approach may be appropriate for you.

• Lower cheek fillers and jawline bio-remodelling address different aspects of lower facial ageing — structural volume loss and skin quality, respectively — and may complement one another when used together where clinically appropriate.
• Jowl formation is a natural part of the ageing process, driven by volume redistribution, collagen loss, bone remodelling, and ligamentous laxity.
• No injectable treatment can replicate the results of surgery in cases of significant tissue laxity or excess; these treatments are most relevant for early or mild changes.
• Results vary between individuals and are influenced by anatomy, lifestyle, and individual response to treatment.
• Risks exist with all injectable treatments, and treatment should only be performed by a qualified, appropriately trained practitioner in a regulated clinical environment.
• A professional consultation is essential before any treatment is considered; suitability cannot be determined without individual assessment.

Is the pre-jowl combination treatment suitable for everyone experiencing jowling?

No. Suitability for lower cheek fillers paired with jawline bio-remodelling depends on the degree of tissue descent, skin quality, facial anatomy, and an individual's medical history. In cases of significant tissue laxity or excess, surgical options may be more appropriate. A qualified practitioner will assess your individual circumstances during a consultation and advise on whether any treatment is suitable for you. No treatment decision should be made without a thorough in-person assessment.

At what age do people typically start noticing pre-jowl changes?

Early signs of jowl formation and lower facial softening can begin in the mid-to-late thirties, though this varies significantly between individuals. Genetics, lifestyle factors such as smoking and sun exposure, and skin type all influence the rate at which these changes become visible. There is no set age at which treatment should be considered; the decision is always based on individual concerns and clinical assessment rather than age alone.

How many sessions of jawline bio-remodelling are typically recommended?

Bio-remodelling treatments for the jawline and lower face are typically administered as a course of two sessions, spaced approximately four weeks apart, to allow the bio-remodelling process to develop progressively. Maintenance sessions are then usually recommended every six to twelve months, depending on individual response and practitioner guidance. This may vary depending on the specific product used and the patient's individual skin characteristics. Your practitioner will advise on an appropriate schedule following assessment.

Can lower cheek fillers make jowls worse if placed incorrectly?

Incorrect filler placement in the lower face is a recognised risk and underlines the importance of selecting a practitioner with appropriate anatomical knowledge, training, and experience. Filler placed at an inappropriate depth or location could theoretically contribute to undesirable soft tissue changes. This is one of the primary reasons why injectable treatments should only be performed by qualified medical professionals who thoroughly understand facial anatomy and have access to hyaluronidase for complication management.

How long before I see results from these treatments?

Lower cheek fillers typically produce an immediate visible effect, though some swelling in the days following treatment means the final result becomes clearer over one to two weeks. Bio-remodelling results are more gradual, as they depend on the body's own collagen and elastin synthesis being stimulated over time. Skin quality improvements from bio-remodelling typically become more apparent over four to eight weeks following treatment. Individual results will vary.

Are there any lifestyle changes that can support the results of these treatments?

Several lifestyle factors support skin health and may contribute to maintaining treatment results over time. These include consistent daily use of SPF 30 or above, adequate hydration, a balanced diet rich in antioxidants, avoidance of smoking, and limiting alcohol consumption. Regular use of an evidence-based skincare routine — appropriate to your skin type and concerns — can also support long-term skin quality. Your practitioner may be able to advise on skincare products and habits that complement your treatment plan.

The lower face is often one of the first areas where patients notice meaningful changes in their facial appearance — a softening of the jaw border, early jowl formation, or a loss of the lateral cheek structure that once defined the mid-to-lower face. For patients researching non-surgical options, the combination of lower cheek fillers and jawline bio-remodelling represents a considered, anatomy-informed approach that addresses both the structural and skin quality dimensions of early lower facial ageing.

Understanding the underlying science — volume redistribution, collagen depletion, ligamentous laxity, and bone remodelling — helps contextualise why a combined strategy may be more comprehensive than a single-modality approach. At the same time, it is important to hold realistic expectations: these are not permanent solutions, they are not appropriate for all degrees of tissue change, and results will vary between individuals.

Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation. Patients are encouraged to seek personalised advice from a qualified practitioner before making any decision about aesthetic treatment.